Topic Review
Adoptive Cellular Therapies in Ovarian Cancer
Ovarian cancers are typically poorly immunogenic and have demonstrated disappointing responses to immune checkpoint inhibitor (ICI) therapy. Adoptive cellular therapy (ACT) offers an alternative method of harnessing the immune system that has shown promise, especially with the success of chimeric antigen receptor T-cell (CAR-T) therapy in haematologic malignancies. ACT has led to modest results in the treatment of solid organ malignancies. 
  • 191
  • 17 Oct 2023
Topic Review
Vaccination Hesitancy
Vaccines are an important tool of preventive medicine. Although organized vaccination programs have saved large populations from serious infectious diseases, there is a considerable part of the population who oppose vaccinations. In particular, anti-vaccination perceptions, among travelers to countries with endemic diseases, are a major public health concern.
  • 227
  • 17 Oct 2023
Topic Review
Neoadjuvant Therapy for Oesophageal and Gastro-oesophageal Junction Adenocarcinomas
Historically, oesophageal and gastro-oesophageal junction adenocarcinomas were associated with a poor prognosis. The advent of neoadjuvant therapy has transformed the management of oesophageal and gastro-oesophageal junction adenocarcinomas further and offers the possibility to reverse disease progression, eliminate micrometastasis, and offer potentially better outcomes for these patients.
  • 111
  • 17 Oct 2023
Topic Review
JAK Inhibitors’ Pleiotropic Potential in Pain's Immune Interactions
The exploration of pain within the contexts of rheumatic diseases, immune interactions, and the JAK/STAT signaling pathway reveals the intricate and dynamic interplay between immune responses and neural processes that shape pain perception and modulation. From the complex nature of pain experiences in conditions like rheumatoid arthritis to the bidirectional communication between immune cells and neurons, a comprehensive understanding of these interactions is crucial for developing effective pain management strategies.
  • 265
  • 17 Oct 2023
Topic Review
External Beam Radiotherapy for Cervical Cancer
The standard of care for locally advanced cervical cancer is external beam radiotherapy (EBRT) with simultaneous chemotherapy followed by an internal radiation boost. New imaging methods such as positron-emission tomography and magnetic resonance imaging have been implemented into daily practice for better tumor delineation in radiotherapy planning. The method of delivering radiation has changed with technical advances in qualitative imaging and treatment delivery. Image-guided radiotherapy (IGRT) plays an important role in minimizing treatment toxicity of pelvic radiation and provides a superior conformality for sparing the organs at risk (OARs) such as bone marrow, bowel, rectum, and bladder. 
  • 317
  • 17 Oct 2023
Topic Review
Cyclic Phosphatidic Acid for Treating Osteoarthritis
Osteoarthritis (OA), a chronic degenerative joint disease, is the most common form of arthritis. OA occurs when the protective cartilage that cushions the ends of bones gradually breaks down. This leads to the rubbing of bones against each other, resulting in pain and stiffness. Cyclic phosphatidic acid (cPA) shows promise as a treatment for OA.
  • 140
  • 17 Oct 2023
Topic Review
Cellular, Molecular, Pharmacological, and Nano-Formulation Aspects of Thymoquinone
The goal of an antiviral agent research is to find an antiviral drug that reduces viral growth without harming healthy cells. Transformations of the virus, new viral strain developments, the resistance of viral pathogens, and side effects are the current challenges in terms of discovering antiviral drugs. The time has come and it is now essential to discover a natural antiviral agent that has the potential to destroy viruses without causing resistance or other unintended side effects. The pharmacological potency of thymoquinone (TQ) against different communicable and non-communicable diseases has been proven by various studies, and TQ is considered to be a safe antiviral substitute. 
  • 176
  • 17 Oct 2023
Topic Review
Selected African Medicinal Plants against Multi-Drug-Resistant Bacteria
Antimicrobial resistance is considered a “One-Health” problem, impacting humans, animals, and the environment. The problem of the rapid development and spread of bacteria resistant to multiple antibiotics is a rising global health threat affecting both rich and poor nations. Low- and middle-income countries are at highest risk, in part due to the lack of innovative research on the surveillance and discovery of novel therapeutic options. Fast and effective drug discovery is crucial towards combatting antimicrobial resistance and reducing the burden of infectious diseases. African medicinal plants have been used for millennia in folk medicine to cure many diseases and ailments. Over 10% of the Southern African vegetation is applied in traditional medicine, with over 15 species being partially or fully commercialized. These include the genera Euclea, Ficus, Aloe, Lippia. And Artemisia, amongst many others. Bioactive compounds from indigenous medicinal plants, alone or in combination with existing antimicrobials, offer promising solutions towards overcoming multi-drug resistance. Secondary metabolites have different mechanisms and modes of action against bacteria, such as the inhibition and disruption of cell wall synthesis; inhibition of DNA replication and ATP synthesis; inhibition of quorum sensing; inhibition of AHL or oligopeptide signal generation, broadcasting, and reception; inhibition of the formation of biofilm; disruption of pathogenicity activities; and generation of reactive oxygen species.
  • 209
  • 17 Oct 2023
Topic Review
Colorectal Cancer Screening and Diagnostics
Colorectal cancer (CRC) is a prevalent and potentially fatal disease categorized based on its high incidences and mortality rates, which raised the need for effective diagnostic strategies for the early detection and management of CRC. While there are several conventional cancer diagnostics available, they have certain limitations that hinder their effectiveness. 
  • 304
  • 17 Oct 2023
Topic Review
Pre-Marketing Evidence on SMA Pharmacological Therapies
Spinal muscular atrophy (SMA) is a rare neuromuscular disease, with an estimated incidence of about 1 in 10,000 live births. To date, three orphan drugs have been approved for the treatment of SMA: nusinersen, onasemnogene abeparvovec, and risdiplam.
  • 201
  • 17 Oct 2023
  • Page
  • of
  • 1349
Video Production Service